NCT03602612
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Clinical trial condition
Lymphoproliferative Disorders
Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.
10,121 public trials
2,033 recruiting studies
Lymphoproliferative Disorders trial results
NCT01644799
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States
- University of Chicago Chicago, Illinois, United States
- Washington University School of Medicine St Louis, Missouri, United States
- Weill Medical College of Cornell University New York, United States
Completed
Daratumumab and Ibrutinib in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia
NCT03447808
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Local Institution - 126 Tucson, Arizona, United States
- Local Institution - 137 Greenbrae, California, United States
- Local Institution - 109 Los Angeles, California, United States
- Local Institution - 104 Pleasant Hill, California, United States
NCT04737265
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +23 more
- Locations
-
- City of Hope Duarte, California, United States
- Abramson Cancer Center at University of Pennsylvania Philadelphia, Pennsylvania, United States
- Chester County Hospital West Chester, Pennsylvania, United States
NCT03570892
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Moores UC San Diego Cancer Center La Jolla, California, United States
- University of California Los Angeles Los Angeles, California, United States
- UCSF Medical Center San Francisco, California, United States
- Sarah Cannon Research Institute Denver, Colorado, United States
NCT02761564
- Conditions
- Anemia, Anemia (<9g/dL) Requiring Blood Transfusion, Bleeding Graded as Insignificant, Mild, Moderate of Universal Definition of Perioperative Bleeding, +14 more
- Locations
-
- UHMontpellier Montpellier, France
NCT03703375
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Local Institution - 41822 Sapporo, Hokkaido, Japan
- Local Institution - 41922 Okayama, Okayama-ken, Japan
- Local Institution - 41722 Sayama, Osaka, Japan
- Local Institution - 41422 Hidaka, Saitama-Pref, Japan
NCT04113226
- Conditions
- Chemotherapy, Dendritic Cell Sarcoma, Interdigitating, Diffuse Large B-Cell Lymphoma (DLBCL), Nos, +18 more
- Locations
-
- CHU Amiens Amiens, France
NCT07644351
- Conditions
- Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
- Locations
-
- Novartis Investigative Site Boston, Massachusetts, United States
- Novartis Investigative Site Sydney, New South Wales, Australia
- Novartis Investigative Site Montreal, Canada
- Novartis Investigative Site Hong Kong, China